{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:54Z","timestamp":1793995614746,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8133","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Targeted protein degradation is a powerful pharmacological strategy that harnesses the ubiquitin proteasome system to eliminate disease-relevant proteins, including otherwise undruggable proteins\n                    <jats:sup>1<\/jats:sup>\n                    . Here we report an unbiased and broadly applicable platform for the systematic discovery of molecular glues across diverse E3 ligases. Using multiplexed mass spectrometry-based chemical screening, we identified M12, a molecular glue that reprogrammes the E3 ligase DCAF11 to degrade DDX18. Mechanistically, M12 functions as a prodrug that is activated through glutathione\n                    <jats:italic>S<\/jats:italic>\n                    -transferase-mediated glutathionylation. The glutathione moiety binds to an evolutionary conserved glutathione-binding site on DCAF11, and the exposed M12 moiety facilitates neo-substrate recruitment. We demonstrate that this glutathione-dependent mechanism readily enables targeted degradation of a range of proteins. Collectively, these findings establish that metabolically activated compounds can redirect E3 ligase function, thereby expanding the scope of targeted protein degradation and chemically induced proximity.\n                  <\/jats:p>","DOI":"10.1038\/s41586-026-10873-1","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:02:00Z","timestamp":1785942120000},"page":"1045-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["DCAF11-dependent molecular glue degrader activated by glutathionylation"],"prefix":"10.1038","volume":"657","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-5489","authenticated-orcid":false,"given":"Hojong","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9185-3612","authenticated-orcid":false,"given":"Franziska","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rodr\u00edguez-P\u00f6hnlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-0887","authenticated-orcid":false,"given":"Justine C.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Lumpkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Metivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-4936","authenticated-orcid":false,"given":"Kheewoong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7553-4806","authenticated-orcid":false,"given":"Robert W.","family":"Kalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-8267","authenticated-orcid":false,"given":"Yuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-6306","authenticated-orcid":false,"given":"Eric S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5451","authenticated-orcid":false,"given":"Benjamin L.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"10873_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.chembiol.2021.04.011","volume":"28","author":"KTG Samarasinghe","year":"2021","unstructured":"Samarasinghe, K. T. G. & Crews, C. M. Targeted protein degradation: a promise for undruggable proteins. Cell Chem. Biol. 28, 934\u2013951 (2021).","journal-title":"Cell Chem. Biol."},{"key":"10873_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nature05731","volume":"446","author":"X Tan","year":"2007","unstructured":"Tan, X. et al. Mechanism of auxin perception by the TIR1 ubiquitin ligase. Nature 446, 640\u2013645 (2007).","journal-title":"Nature"},{"key":"10873_CR3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","volume":"28","author":"Z Kozicka","year":"2021","unstructured":"Kozicka, Z. & Thoma, N. H. Haven\u2019t got a glue: protein surface variation for the design of molecular glue degraders. Cell Chem. Biol. 28, 1032\u20131047 (2021).","journal-title":"Cell Chem. Biol."},{"key":"10873_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301\u2013305 (2014).","journal-title":"Science"},{"key":"10873_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305\u2013309 (2014).","journal-title":"Science"},{"key":"10873_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer, E. S. et al. Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512, 49\u201353 (2014).","journal-title":"Nature"},{"key":"10873_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","volume":"532","author":"G Petzold","year":"2016","unstructured":"Petzold, G., Fischer, E. S. & Thoma, N. H. Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase. Nature 532, 127\u2013130 (2016).","journal-title":"Nature"},{"key":"10873_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat0572","volume":"362","author":"QL Sievers","year":"2018","unstructured":"Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362, eaat0572 (2018).","journal-title":"Science"},{"key":"10873_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer, M., Spiteri, V. A., Ciulli, A. & Winter, G. E. Targeted protein degradation for cancer therapy. Nat. Rev. Cancer 25, 493\u2013516 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"10873_CR10","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1182\/blood.2020005827","volume":"136","author":"A Subramaniam","year":"2020","unstructured":"Subramaniam, A. et al. Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171. Blood 136, 2151\u20132161 (2020).","journal-title":"Blood"},{"key":"10873_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.stem.2020.12.002","volume":"28","author":"J Chagraoui","year":"2021","unstructured":"Chagraoui, J. et al. UM171 preserves epigenetic marks that are reduced in ex vivo culture of human HSCs via potentiation of the CLR3\u2013KBTBD4 complex. Cell Stem Cell 28, 48\u201362.e46 (2021).","journal-title":"Cell Stem Cell"},{"key":"10873_CR12","doi-asserted-by":"publisher","first-page":"104662","DOI":"10.1016\/j.jbc.2023.104662","volume":"299","author":"K Zemaitis","year":"2023","unstructured":"Zemaitis, K., Ghosh, S., Hansson, J. & Subramaniam, A. The stem cell-supporting small molecule UM171 triggers Cul3\u2013KBTBD4-mediated degradation of ELM2 domain-harboring proteins. J. Biol. Chem. 299, 104662 (2023).","journal-title":"J. Biol. Chem."},{"key":"10873_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal3755","volume":"356","author":"T Han","year":"2017","unstructured":"Han, T. et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science 356, eaal3755 (2017).","journal-title":"Science"},{"key":"10873_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-020-2374-x","volume":"585","author":"M Slabicki","year":"2020","unstructured":"Slabicki, M. et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature 585, 293\u2013297 (2020).","journal-title":"Nature"},{"key":"10873_CR15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","volume":"16","author":"C Mayor-Ruiz","year":"2020","unstructured":"Mayor-Ruiz, C. et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat. Chem. Biol. 16, 1199\u20131207 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"10873_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s41589-025-01936-x","volume":"21","author":"A Tutter","year":"2025","unstructured":"Tutter, A. et al. A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1. Nat. Chem. Biol. 21, 1688\u20131696 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"10873_CR17","doi-asserted-by":"publisher","unstructured":"Bushman, J. W. et al. Discovery of a VHL molecular glue degrader of GEMIN3 by Picowell RNA-seq. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.03.19.644003 (2025).","DOI":"10.1101\/2025.03.19.644003"},{"key":"10873_CR18","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cell.2020.10.038","volume":"183","author":"KA Donovan","year":"2020","unstructured":"Donovan, K. A. et al. Mapping the degradable kinome provides a resource for expedited degrader development. Cell 183, 1714\u20131731.e1710 (2020).","journal-title":"Cell"},{"key":"10873_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62099-w","volume":"16","author":"K Baek","year":"2025","unstructured":"Baek, K. et al. Unveiling the hidden interactome of CRBN molecular glues. Nat. Commun. 16, 6831 (2025).","journal-title":"Nat. Commun."},{"key":"10873_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature18611","volume":"535","author":"ME Matyskiela","year":"2016","unstructured":"Matyskiela, M. E. et al. A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. Nature 535, 252\u2013257 (2016).","journal-title":"Nature"},{"key":"10873_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","volume":"67","author":"GE Winter","year":"2017","unstructured":"Winter, G. E. et al. BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol. Cell 67, 5\u201318.e19 (2017).","journal-title":"Mol. Cell"},{"key":"10873_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.celrep.2019.12.021","volume":"30","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. DEAD-box helicase 18 counteracts PRC2 to safeguard ribosomal DNA in pluripotency regulation. Cell Rep. 30, 81\u201397.e87 (2020).","journal-title":"Cell Rep."},{"key":"10873_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tibs.2010.07.008","volume":"36","author":"E Jankowsky","year":"2011","unstructured":"Jankowsky, E. RNA helicases at work: binding and rearranging. Trends Biochem. Sci. 36, 19\u201329 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"10873_CR24","doi-asserted-by":"publisher","first-page":"111089","DOI":"10.1016\/j.celrep.2022.111089","volume":"40","author":"WL Lin","year":"2022","unstructured":"Lin, W. L. et al. DDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1. Cell Rep. 40, 111089 (2022).","journal-title":"Cell Rep."},{"key":"10873_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh3892","volume":"381","author":"A Vanden Broeck","year":"2023","unstructured":"Vanden Broeck, A. & Klinge, S. Principles of human pre-60S biogenesis. Science 381, eadh3892 (2023).","journal-title":"Science"},{"key":"10873_CR26","first-page":"409","volume":"2","author":"PJ Shami","year":"2003","unstructured":"Shami, P. J. et al. JS-K, a glutathione\/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol. Cancer Ther. 2, 409\u2013417 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"10873_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0166-445X(99)00107-1","volume":"50","author":"MS Stoelting","year":"2000","unstructured":"Stoelting, M. S. & Tjeerdema, R. S. Glutathione-dependent biotransformation of 1-chloro-2,4-dinitrobenzene in arterial and venous blood of the striped bass (Morone saxitilis). Aquat. Toxicol. 50, 177\u2013187 (2000).","journal-title":"Aquat. Toxicol."},{"key":"10873_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1124\/mol.106.025288","volume":"70","author":"BI Eklund","year":"2006","unstructured":"Eklund, B. I., Moberg, M., Bergquist, J. & Mannervik, B. Divergent activities of human glutathione transferases in the bioactivation of azathioprine. Mol. Pharmacol. 70, 747\u2013754 (2006).","journal-title":"Mol. Pharmacol."},{"key":"10873_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10873_CR30","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1021\/jacs.1c00990","volume":"143","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. DCAF11 supports targeted protein degradation by electrophilic proteolysis-targeting chimeras. J. Am. Chem. Soc. 143, 5141\u20135149 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"10873_CR31","doi-asserted-by":"publisher","first-page":"e202500035","DOI":"10.1002\/cmdc.202500035","volume":"20","author":"F Feller","year":"2025","unstructured":"Feller, F. et al. Replacing a cereblon ligand by a DDB1 and CUL4 associated factor 11 (DCAF11) recruiter converts a selective histone deacetylase 6 PROTAC into a pan-degrader. ChemMedChem 20, e202500035 (2025).","journal-title":"ChemMedChem"},{"key":"10873_CR32","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acs.jmedchem.5c02188","volume":"69","author":"J Liang","year":"2026","unstructured":"Liang, J. et al. Arylidene-thiazoldione scaffold acts as the E3 ligand of DCAF11 for PROTAC design. J. Med. Chem. 69, 2349\u20132369 (2026).","journal-title":"J. Med. Chem."},{"key":"10873_CR33","doi-asserted-by":"publisher","first-page":"129779","DOI":"10.1016\/j.bmcl.2024.129779","volume":"107","author":"G Tin","year":"2024","unstructured":"Tin, G. et al. Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins. Bioorg. Med. Chem. Lett. 107, 129779 (2024).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10873_CR34","doi-asserted-by":"publisher","unstructured":"Zhuang, Z. et al. Discovery of electrophilic degraders that exploit S(N)Ar chemistry. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.25.615094 (2024).","DOI":"10.1101\/2024.09.25.615094"},{"key":"10873_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","volume":"627","author":"O Hsia","year":"2024","unstructured":"Hsia, O. et al. Targeted protein degradation via intramolecular bivalent glues. Nature 627, 204\u2013211 (2024).","journal-title":"Nature"},{"key":"10873_CR36","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1158\/1535-7163.MCT-24-0219","volume":"23","author":"GS Parker","year":"2024","unstructured":"Parker, G. S. et al. Discovery of monovalent direct degraders of BRD4 that act via the recruitment of DCAF11. Mol. Cancer Ther. 23, 1446\u20131458 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"10873_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.chembiol.2017.10.005","volume":"25","author":"HT Huang","year":"2018","unstructured":"Huang, H. T. et al. A chemoproteomic approach to query the degradable kinome using a multi-kinase degrader. Cell Chem. Biol. 25, 88\u201399.e86 (2018).","journal-title":"Cell Chem. Biol."},{"key":"10873_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fphar.2014.00196","volume":"5","author":"K Aquilano","year":"2014","unstructured":"Aquilano, K., Baldelli, S. & Ciriolo, M. R. Glutathione: new roles in redox signaling for an old antioxidant. Front. Pharmacol. 5, 196 (2014).","journal-title":"Front. Pharmacol."},{"key":"10873_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","volume":"17","author":"MP Gamcsik","year":"2012","unstructured":"Gamcsik, M. P., Kasibhatla, M. S., Teeter, S. D. & Colvin, O. M. Glutathione levels in human tumors. Biomarkers 17, 671\u2013691 (2012).","journal-title":"Biomarkers"},{"key":"10873_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).","journal-title":"Science"},{"key":"10873_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41586-022-05333-5","volume":"610","author":"S Ichikawa","year":"2022","unstructured":"Ichikawa, S. et al. The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron. Nature 610, 775\u2013782 (2022).","journal-title":"Nature"},{"key":"10873_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-024-08475-w","volume":"638","author":"MF Muhar","year":"2025","unstructured":"Muhar, M. F. et al. C-terminal amides mark proteins for degradation via SCF-FBXO31. Nature 638, 519\u2013527 (2025).","journal-title":"Nature"},{"key":"10873_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"10873_CR44","doi-asserted-by":"publisher","first-page":"W344","DOI":"10.1093\/nar\/gkw408","volume":"44","author":"H Ashkenazy","year":"2016","unstructured":"Ashkenazy, H. et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 44, W344\u2013W350 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10873_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ab.2008.10.044","volume":"385","author":"W Abdulrahman","year":"2009","unstructured":"Abdulrahman, W. et al. A set of baculovirus transfer vectors for screening of affinity tags and parallel expression strategies. Anal. Biochem. 385, 383\u2013385 (2009).","journal-title":"Anal. Biochem."},{"key":"10873_CR46","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1021\/acs.jmedchem.4c02415","volume":"68","author":"Q Geng","year":"2025","unstructured":"Geng, Q. et al. Development of potent and selective CK1 \u03b1 molecular glue degraders. J. Med. Chem. 68, 3180\u20133196 (2025).","journal-title":"J. Med. Chem."},{"key":"10873_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"10873_CR48","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41589-024-01668-4","volume":"20","author":"YD Li","year":"2024","unstructured":"Li, Y. D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. 20, 1640\u20131649 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"10873_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10873_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"10873_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"10873_CR52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"10873_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"10873_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"10873_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).","journal-title":"eLife"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10873-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10873-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:02:35Z","timestamp":1790442155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10873-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":55,"journal-issue":{"issue":"8133","published-print":{"date-parts":[[2026,9,24]]}},"alternative-id":["10873"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10873-1","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.L.E. has received research funding from Novartis and Calico and consulting fees from Abbvie. B.L.E. is a member of the scientific advisory board and shareholder for Neomorph, Big Sur Bio, Skyhawk Therapeutics and Exo Therapeutics. E.S.F. is a founder, scientific advisory board member and equity holder of Civetta Therapeutics, Proximity Therapeutics, Neomorph (serving on the board of directors), Stelexis Biosciences, Anvia Therapeutics (serving on the board of directors), Nias Bio and Vasetto Bio (serving on the board of directors). E.S.F. is an equity holder in Avilar Therapeutics, Ajax Therapeutics (serving as a member of the scientific advisory board), Photys Therapeutics (serving as a member of the scientific advisory board), HiddenSee Therapeutics and Lighthorse Therapeutics. E.S.F. is a consultant to GSK, Novartis and Deerfield. The Fischer laboratory receives or has received research funding from Deerfield, Novartis, Ajax, Interline, Bayer and Astellas. K.A.D. receives or has received consulting fees from Neomorph and Kronos Bio. J.C. is a co-founder for Matchpoint Therapeutics and M3Bioinformatics&Technology. J.C. is a consultant and equity holder for Matchpoint, Soltego and Allorion. J.C. has received sponsored research support from Springworks and Deerfield. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}